Roberts Glore & Co Inc Buys Abbott Laboratories, AbbVie Inc, Johnson & Johnson, Sells Berkshire Hathaway Inc, Berkshire Hathaway Inc, Bio-Techne Corp

• New Purchases: VEU, VIAC, VXUS, MOAT, QCRH, EEM, MDY, VTV, WFC, MMM, VYM, GWW, AMCX, BAC, RYN, APH, NWL, SSB, RPM, PCH, NEM, ILMN, GPN, SAM, TAP, CB, ALXN, OZK, VOO, SLB, SMG, CMP, MA, FFIV, MKC, CSX, EPD, EMF, WY, JW.A, LKQ, MXIM, SAMG, JOF, LWAY,
• Added Positions: ABT, ABBV, JNJ, AAPL, VTI, MSFT, ITW, VPL, WIW, GOOG, PEP, BAB, WIA, ATRI, CSCO, GOOGL, SBUX, UNP, VWO, SYK, UTX, PG, XOM, INTC, BABA, MGV, WMT, WBA, DIS, AMGN, EXPD, CEF, GIS, GILD, MTB, NSC, AMZN, SPY, VIG, BIIB, VTEB, CVS, VCSH, CHRW, DGX, VMBS, NVS, WAB, ETR, IEFA, BND, QVAL, CME, KO, FDX, MRK, BKNG, BAX, AGN, BIDU, CNC, LHX, COP, PYPL, CVX, ORCL, BDX, CERN, SRCL, ADX, GE, MDT, ZBH, CET, T, EXPE, STT, CMCSA, DE, INTU, SJM, NTRS, SO, GD, ANET, FAST, LMT, TGT, DFJ, AAP, FLO, VZ, MYI, VBR, VNQ, ABC, BLK, DCI, HD, IFF, NVDA, NTR, UN, EBAY, PSX, FB, TROW, RMT, PCTY, FDS, PAYX, PFE, IYM, TIP, ADP, LOW, SU, TRP, BP, CNI, RJI, NOC, CBOE, AB,
• Reduced Positions: LIN, DFS, CHD,
• Sold Out: BRK.B, BRK.A, TECH, PHO, BAYRY, VIAB, HYG, SFTBY, RHHBY, RDS.A, CI, DCMYY,

For the details of ROBERTS GLORE & CO INC 's stock buys and sells, go to https://www.gurufocus.com/guru/roberts+glore+%26+co+inc+/current-portfolio/portfolio

1. Johnson & Johnson (JNJ) - 77,667 shares, 4.34% of the total portfolio. Shares added by 54.13%
2. Microsoft Corp (MSFT) - 66,618 shares, 4.03% of the total portfolio. Shares added by 38.58%
3. Apple Inc (AAPL) - 35,231 shares, 3.96% of the total portfolio. Shares added by 59.84%
4. Abbott Laboratories (ABT) - 111,111 shares, 3.70% of the total portfolio. Shares added by 194.24%
5. Vanguard FTSE Pacific (VPL) - 107,962 shares, 2.88% of the total portfolio. Shares added by 46.89%

Roberts Glore & Co Inc initiated holding in Vanguard FTSE All World Ex US. The purchase prices were between $48.63 and $54.07, with an estimated average price of $52.01. The stock is now traded at around $50.84. The impact to a portfolio due to this purchase was 0.37%. The holding were 18,129 shares as of .

Roberts Glore & Co Inc initiated holding in ViacomCBS Inc. The purchase prices were between $35.58 and $42.66, with an estimated average price of $38.79. The stock is now traded at around $26.93. The impact to a portfolio due to this purchase was 0.25%. The holding were 15,418 shares as of .

Roberts Glore & Co Inc initiated holding in Vanguard Total International Stock. The purchase prices were between $50.39 and $55.96, with an estimated average price of $53.83. The stock is now traded at around $52.55. The impact to a portfolio due to this purchase was 0.24%. The holding were 11,268 shares as of .

Roberts Glore & Co Inc initiated holding in VanEck Vectors Morningstar Wide Moat. The purchase prices were between $48.49 and $55.64, with an estimated average price of $53.03. The stock is now traded at around $54.24. The impact to a portfolio due to this purchase was 0.22%. The holding were 10,330 shares as of .

Roberts Glore & Co Inc initiated holding in QCR Holdings Inc. The purchase prices were between $36.99 and $44.08, with an estimated average price of $40.92. The stock is now traded at around $41.34. The impact to a portfolio due to this purchase was 0.2%. The holding were 11,690 shares as of .

Roberts Glore & Co Inc initiated holding in iShares MSCI Emerging Index Fund. The purchase prices were between $39.43 and $45.07, with an estimated average price of $42.23. The stock is now traded at around $41.67. The impact to a portfolio due to this purchase was 0.2%. The holding were 11,418 shares as of .

Roberts Glore & Co Inc added to a holding in Abbott Laboratories by 194.24%. The purchase prices were between $78.51 and $87.4, with an estimated average price of $83.86. The stock is now traded at around $84.71. The impact to a portfolio due to this purchase was 2.44%. The holding were 111,111 shares as of .

Roberts Glore & Co Inc added to a holding in AbbVie Inc by 228.31%. The purchase prices were between $72.13 and $90.25, with an estimated average price of $83.36. The stock is now traded at around $93.21. The impact to a portfolio due to this purchase was 1.95%. The holding were 82,510 shares as of .

Roberts Glore & Co Inc added to a holding in Johnson & Johnson by 54.13%. The purchase prices were between $127.5 and $146.44, with an estimated average price of $135.91. The stock is now traded at around $146.21. The impact to a portfolio due to this purchase was 1.52%. The holding were 77,667 shares as of .

Roberts Glore & Co Inc added to a holding in Vanguard Total Stock Market by 174.85%. The purchase prices were between $146.61 and $164.29, with an estimated average price of $156.97. The stock is now traded at around $164.30. The impact to a portfolio due to this purchase was 1.48%. The holding were 37,050 shares as of .

Roberts Glore & Co Inc added to a holding in Apple Inc by 59.84%. The purchase prices were between $218.96 and $293.65, with an estimated average price of $258.41. The stock is now traded at around $298.75. The impact to a portfolio due to this purchase was 1.48%. The holding were 35,231 shares as of .

Roberts Glore & Co Inc added to a holding in Microsoft Corp by 38.58%. The purchase prices were between $134.65 and $158.96, with an estimated average price of $147.3. The stock is now traded at around $171.00. The impact to a portfolio due to this purchase was 1.12%. The holding were 66,618 shares as of .

Roberts Glore & Co Inc sold out a holding in Berkshire Hathaway Inc. The sale prices were between $203.1 and $227.05, with an estimated average price of $217.51.

Roberts Glore & Co Inc sold out a holding in Berkshire Hathaway Inc. The sale prices were between $305090 and $340380, with an estimated average price of $326054.

Roberts Glore & Co Inc sold out a holding in Bio-Techne Corp. The sale prices were between $191.54 and $222.09, with an estimated average price of $210.52.

Roberts Glore & Co Inc sold out a holding in Invesco Water Resources ETF. The sale prices were between $34.86 and $38.72, with an estimated average price of $37.14.

Roberts Glore & Co Inc sold out a holding in Bayer AG. The sale prices were between $16.74 and $20.68, with an estimated average price of $19.03.

Roberts Glore & Co Inc sold out a holding in iShares iBoxx $ High Yield Corporate Bond. The sale prices were between $84.69 and $87.59, with an estimated average price of $86.05.